Please login to the form below

Not currently logged in
Email:
Password:

Former Ketchum head joins Luther Pendragon

Avril Lee becomes director at the corporate communications consultancy
 

Avril LeeLuther Pendragon has named Avril Lee – former CEO of Ketchum – as director of the communications consultancy.

Lee joins Luther Pendragon after a decade at Ketchum, initially running the healthcare team in London and then Europe, before being appointed CEO for the UK in 2011.

Before joining Ketchum, Lee was deputy MD and a board director at Hill & Knowlton. She is a member of council at the Public Relations Consultants Association (PRCA) and a spokesperson for the Chartered Institute of Public Relations' (CIPR) diversity working group.

Luther Pendragon managing director Simon Whale said he was delighted to have Lee join.

"She is one of the very best in communications, she has a fantastic track record and she brings a wealth of management experience. She is perfectly suited to our integrated, intelligent approach to communications and our broad client base,” he said.

Lee added: "Luther Pendragon is exactly what I was looking for – its plans for growth match my own ambitions and I'm really looking forward to contributing to its continued success."

Whale and Lee will co-lead on healthcare, although she will also work on other client sectors. Luther Pendragon's current healthcare clients include pharmaceutical and other commercial healthcare companies, trade associations, professional bodies and healthcare regulators.


31st October 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...